Blueprint Medicines
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Blueprint Medicines's past years’ income statements indicate that its last revenue has increased compared to the previous period by 22% to $249,380,000. The net income raised on -$506,984,000 and profit margin reached -203%. Total operating expenses were $722,861,000.
Profit Margin
| 2014 | 0 | -40.28M | |
|---|---|---|---|
| 2015 | 11.4M | -52.76M | -462.89% |
| 2016 | 27.77M | -72.49M | -261.04% |
| 2017 | 21.42M | -148.11M | -691.3% |
| 2018 | 44.52M | -236.64M | -531.53% |
| 2019 | 66.51M | -328.70M | -494.2% |
| 2020 | 793.73M | 313.88M | 39.54% |
| 2021 | 180.08M | -644.08M | -357.67% |
| 2022 | 204.03M | -557.51M | -273.24% |
| 2023 | 249.38M | -506.98M | -203.3% |
BPMC Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 249.38M | 204.03M | 180.08M | 793.73M | 66.51M | 44.52M | 21.42M | 27.77M | 11.4M | 0 |
Cost of revenue | 12.79M | 17.81M | 17.93M | 425K | 0 | 0 | 144.68M | 0 | 48.58M | 31.84M |
Gross profit | 236.58M | 186.22M | 162.14M | 793.31M | 66.51M | 44.52M | -123.26M | 27.77M | -37.18M | -31.84M |
Operating exp. | ||||||||||
Research and development | 427.72M | 477.41M | 601.03M | 326.86M | 331.45M | 243.62M | 144.68M | 81.13M | 48.58M | 31.84M |
Selling and marketing | 16.9M | 18.1M | 13.5M | 9.4M | 3.3M | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 722.86M | 723.74M | 804.12M | 484.60M | 427.83M | 291.54M | 172.67M | 100.34M | 63.04M | 39.73M |
Operating income | -486.27M | -549.25M | -648.46M | 302.14M | -366.58M | -247.02M | -149.47M | -73.60M | -53.02M | -39.83M |
Other income (expenses), net | -19.73M | -3.02M | 7.37M | 6.23M | 18.89M | 10.45M | 3.12M | 551K | -1.12M | -551K |
Income before tax | -506.01M | -552.28M | -641.08M | 314.94M | -347.69M | -236.64M | -148.11M | -72.49M | -52.76M | -40.28M |
Income tax expense | 968K | 5.23M | 3.00M | 1.05M | -18.99M | 10.45M | 1.99M | -562K | -681K | 355K |
Net income | -506.98M | -557.51M | -644.08M | 313.88M | -328.70M | -236.64M | -148.11M | -72.49M | -52.76M | -40.28M |
Earnings per share | ||||||||||
Basic EPS | -8.37 | -9.35 | -11.01 | 5.76 | -6.87 | -5.39 | -3.92 | -2.64 | -2.89 | -3.08 |
Diluted EPS | -8.37 | -9.35 | -11.01 | 5.59 | -6.87 | -5.39 | -3.92 | -2.64 | -2.89 | -3.08 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |